Medical-device certificationEvidence brief

How does Scarlet make medical-software certification a focused offer?

Scarlet’s supplied company profile establishes a specialized starting point rather than a complete sales history. Entrepreneurs First identifies the business as founded in 2021 by James Dewar and Jamie Cox to serve software and AI medical-device certification. It describes Dewar’s computer-science and machine-learning training and the founders’ Babylon Health experience. The combination makes technical understanding and assessment credibility central to interpreting the commercial proposition. [1]

Evidence and interpretation

Partial evidence: this is a critical reading of a limited source record, not a complete reconstruction of the company’s growth. [Inference] marks analysis. Source numbers keep the numbering of the full case, and the evidence is from the 10 Nov 2026 research edition. Read the research method.

The customer is buying a consequential service

The source identifies Dewar as CEO, with computer-science study at Goldsmiths and machine-learning study at Imperial, and Cox as CTO with a medical and software background. It does not identify the first paying customer, reconstruct founder-led sales or provide a complete early hiring sequence. The evidence supports specialization and relevant capabilities, but not a claim that a particular credential or relationship produced the first contract. [1]

[Inference] Developers of software and AI medical devices face a more complex purchase than choosing a convenient productivity application. Technical documentation, quality systems and assessment responsibility shape the work. A prospective customer needs to understand what the service covers and how the process will be conducted. The useful beachhead is therefore defined by a specific assessment need, not merely by enthusiasm for AI or healthcare technology.

Speed is valuable within a credible process

[Inference] A faster service can matter when a company needs an assessment completed, but speed cannot be separated from the credibility of the work. The buyer’s desire for a convenient timeline is not the same as evidence that a device satisfies the relevant assessment criteria. A clear commercial proposition should distinguish responsiveness, process clarity and technical expertise from any promise of a favorable outcome.

[Inference] This distinction also affects the decision-making unit. Product and engineering staff may supply technical material, while quality and organizational leaders own other parts of the process. The supplier needs to make responsibilities understandable across that group. The supplied profile does not establish Scarlet’s exact sales stages, contracting model or customer onboarding measures, so these are questions for evaluating the service rather than verified operating procedures.

Domain knowledge needs to become a dependable experience

The founders’ Babylon Health experience is documented in the source, but the record does not establish individual account managers, formal success ownership or measured enablement conversion. It also does not disclose renewal cohorts. Relevant prior work can explain why the founders understood the subject matter; it cannot prove that every customer received a consistent experience or that the commercial organization had already become repeatable. [1]

[Inference] A useful delivery assessment would examine whether customers understand what information is needed, how questions are resolved and where decisions remain independent. Repeated clarification requests could reveal opportunities to improve guidance without weakening scrutiny. That kind of enablement differs from helping users click through a software interface: it makes a demanding professional process navigable while retaining its substantive requirements and boundaries. Clear preparation guidance can reduce avoidable confusion while leaving substantive assessment questions fully open.

A continuing relationship must preserve independent judgment

Exact current pricing, acquisition costs, payback and retention were not verified in this brief. No failed-channel experiment or complete causal growth explanation was established either. Product updates and repeated assessments could support continuing relationships, but the supplied evidence does not quantify that mechanism. A familiar customer or an expanding account should not be treated as evidence about the outcome of a particular assessment. [1]

[Inference] Scarlet’s transferable lesson is to build a focused offer around expertise and process clarity while separating commercial expansion from assessment decisions. Growth could make repeated service more efficient, but the relevant test is whether quality and independence remain credible. A strong revenue story in this category would measure customer experience and delivery effort without turning certification outcomes into targets for the commercial team.

GO DEEPER

Scarlet: the full GTM case

The complete case holds the named people, the economics, the available historical evidence, the critique and the open research questions.

Read Scarlet’s full GTM case

Terms in this story

Founder-led salesBeachhead marketDecision-making unitCustomer onboardingRenewalCustomer retention

Questions behind the story

How do I choose between product-led and sales-led growth?Why does the site leave CAC and retention blank for some companies?All 104 GTM questions answered

Sources

Numbers match the source list of the full Scarlet case. A source’s publication date and the date of the event it reports can differ.

  1. Entrepreneurs First — inspected company evidence Entrepreneurs First